{"entity":{"type":"insider","cik":"0001906486","url":"/insider/0001906486","json_url":"/insider/0001906486.json","name":"Daly Jason B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2024-11-19","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Daly Jason B.","source":"filing","n_filings":5,"first_seen":"2024-11-19","last_seen":"2026-08-13"}],"transactions":[{"id":9293692,"accession":"0001628280-26-056754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-056754","line_url":"/filing/0001628280-26-056754#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210000.0,"shares_display":"210,000","price_per_share":17.4,"price_display":"17.40","price_state":"stated","total_value":3654000.0,"total_display":"3,654,000.00","total_whole":"3,654,000","shares_owned_after":35171.0,"shares_owned_after_display":"35,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-13","scope":"insider"},{"id":9293693,"accession":"0001628280-26-056754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-056754","line_url":"/filing/0001628280-26-056754#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6613.0,"shares_display":"6,613","price_per_share":17.7,"price_display":"17.70","price_state":"stated","total_value":117050.1,"total_display":"117,050.10","total_whole":"117,050","shares_owned_after":245171.0,"shares_owned_after_display":"245,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-13","scope":"insider"},{"id":4251595,"accession":"0001723128-25-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001723128-25-000049","line_url":"/filing/0001723128-25-000049#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":199100.0,"total_display":"199,100.00","total_whole":"199,100","shares_owned_after":10606.0,"shares_owned_after_display":"10,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4238946,"accession":"0001628280-25-011306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-011306","line_url":"/filing/0001628280-25-011306#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46936.0,"shares_display":"46,936","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":409751.28,"total_display":"409,751.28","total_whole":"409,751","shares_owned_after":32606.0,"shares_owned_after_display":"32,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":4238942,"accession":"0001628280-25-011306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-011306","line_url":"/filing/0001628280-25-011306#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43064.0,"shares_display":"43,064","price_per_share":8.88,"price_display":"8.88","price_state":"stated","total_value":382408.32,"total_display":"382,408.32","total_whole":"382,408","shares_owned_after":79542.0,"shares_owned_after_display":"79,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":3059711,"accession":"0001628280-24-049005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-049005","line_url":"/filing/0001628280-24-049005#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13665.0,"shares_display":"13,665","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":114786.0,"total_display":"114,786.00","total_whole":"114,786","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-22","scope":"insider"},{"id":2745139,"accession":"0001628280-24-048437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-048437","line_url":"/filing/0001628280-24-048437#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001906486","owner_name":"Daly Jason B.","owner_display_name":"Daly Jason B.","owner_url":"/insider/0001906486","role":"Officer (SVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43657.0,"shares_display":"43,657","price_per_share":8.61,"price_display":"8.61","price_state":"stated","total_value":375886.77,"total_display":"375,886.77","total_whole":"375,887","shares_owned_after":13665.0,"shares_owned_after_display":"13,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001723128","name":"Amneal Pharmaceuticals, Inc.","url":"/issuer/0001723128","role":"Officer (EVP, Chief Legal Officer)","n_filings":5,"first_seen":"2024-11-19","last_seen":"2026-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001906486","retrieved_at":"2026-08-22T19:03:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}